The ACIP has voted to recommend the use of respiratory syncytial virus (RSV) vac...
The executive order aims to lower prescription prices, but targets the mechanism...
Glycomine’s Series C raise highlights investor confidence in the company amid pr...
The agreement is seen as a win for global health ahead of the US withdrawal from...
Our editorial team dissects the latest developments in the ongoing story of how ...
Lilly plans to submit orforglipron for approval in weight management by the end ...
The FDA has accepted Regeneron Pharmaceuticals’ sBLA for Eylea HD (aflibercept) ...
Bluebird has reaffirmed its support for a proposed acquisition after Ayrmid fail...
Leveraging Trump’s impending tariffs, pharma companies have called on Europe aga...
The US Food and Drug Administration (FDA) has granted approval for Neurelis’ dia...
BMS could soon face competition in the HCM space as Cytokinetics awaits a market...
One concern with in vivo CAR-Ts is the potential insertional mutagenesis of the ...
At the ESCMID Global conference in Austria, the development of climate-informed ...
Coherus BioSciences has completed the sale of its Udenyca (pegfilgrastim-cbqv) f...
The FDA will require an additional Phase III trial for apraglutide, the company'...
